Thus, VE-cadherin serves as an appealing target for CCM, since RhoA, claudin-5, and TGF-β are all deregulated in this disease [9,11,12,21] and are linked to disruption of vascular integrity. This evidence concerns the gene CDH5 and cerebral cavernous malformation.